The DOI matches its Crossref record.
Group Sequential Methods with Applications to Clinical Trials
Abstract
Group sequential methods answer the needs of clinical trial monitoring committees who must assess the data available at an interim analysis. These interim results may provide grounds for terminating the study-effectively reducing costs-or may benefit the general patient population by allowing early dissemination of its findings. Group sequential methods provide a means to balance the ethical and financial advantages of stopping a study early against the risk of an incorrect conclusion.Group Sequential Methods with Applications to Clinical Trials describes group sequential stopping rules designed to reduce average study length and control Type I and II error probabilities. The authors present one-sided and two-sided tests, introduce several families of group sequential tests, and explain how to choose the most appropriate test and interim analysis schedule. Their topics include placebo-controlled randomized trials, bio-equivalence testing, crossover and longitudinal studies, and linear and generalized linear models.Research in group sequential analysis has progressed rapidly over the past 20 years. Group Sequential Methods with Applications to Clinical Trials surveys and extends current methods for planning and conducting interim analyses. It provides straightforward descriptions of group sequential hypothesis tests in a form suited for direct application to a wide variety of clinical trials. Medical statisticians engaged in any investigations planned with interim analyses will find this book a useful and important tool.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31149-3 · Cited by 3,163
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Lakens, D. (2022) · Collabra Psychology · doi:10.1525/collabra.33267 · Cited by 1,962
Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine
Vesikari, T., Matson, D. O., Dennehy, P., Van Damme, P., Santosham, M., Rodriguez, Z., Dallas, M. J., Heyse, J. F., Goveia, M. G., Black, S. B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052664 · Cited by 1,873
Bang, Y.-J., Kim, Y.-W., Yang, H.-K., Chung, H. C., Park, Y.-K., Lee, K. H., Lee, K.-W., Kim, Y. H., Noh, S.-I., Cho, J. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61873-4 · Cited by 1,705
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.15.1967 · Cited by 1,499
Robot-Assisted Therapy for Long-Term Upper-Limb Impairment after Stroke
Lo, A. C., Guarino, P. D., Richards, L. G., Haselkorn, J. K., Wittenberg, G. F., Federman, D. G., Ringer, R. J., Wagner, T. H., Krebs, H. I., Volpe, B. T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911341 · Cited by 1,397
The National Lung Screening Trial: Overview and Study Design
National Lung Screening Trial Research Team (2011) · Radiology · doi:10.1148/radiol.10091808 · Cited by 1,274
Kaufman, H. L., Russell, J., Hamid, O., Bhatia, S., Terheyden, P., D'Angelo, S. P., Shih, K. C., Lebbé, C., Linette, G. P., Milella, M., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30364-3 · Cited by 1,236
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
Olesen, J., Diener, H.-C., Husstedt, I. W., Goadsby, P. J., Hall, D., Meier, U., Pollentier, S., & Lesko, L. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030505 · Cited by 1,189
Trial Sequential Analysis in systematic reviews with meta-analysis
Wetterslev, J., Jakobsen, J. C., & Gluud, C. (2017) · BMC Medical Research Methodology · doi:10.1186/s12874-017-0315-7 · Cited by 1,189
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
Sanyal, A. J., Newsome, P. N., Kliers, I., Østergaard, L. H., Long, M. T., Kjær, M. S., Cali, A. M. G., Bugianesi, E., Rinella, M. E., Roden, M., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2413258 · Cited by 1,115
Imaging biomarker roadmap for cancer studies
O'Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., Boellaard, R., Bohndiek, S. E., Brady, M., Brown, G., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.162 · Cited by 1,091
Vahedi, K., Vicaut, E., Mateo, J., Kurtz, A., Orabi, M., Guichard, J.-P., Boutron, C., Couvreur, G., Rouanet, F., Touzé, E., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.485235 · Cited by 861
Adaptive designs in clinical trials: why use them, and how to run and report them
Pallmann, P., Bedding, A. W., Choodari-Oskooei, B., Dimairo, M., Flight, L., Hampson, L. V., Holmes, J., Mander, A. P., Odondi, L., Sydes, M. R., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1017-7 · Cited by 829
Dember, L. M., Beck, G. J., Allon, M., Delmez, J. A., Dixon, B. S., Greenberg, A., Himmelfarb, J., Vazquez, M. A., Gassman, J. J., Greene, T., et al. (2008) · JAMA · doi:10.1001/jama.299.18.2164 · Cited by 826
Belle, S. H., Burgio, L., Burns, R., Coon, D., Czaja, S. J., Gallagher-Thompson, D., Gitlin, L. N., Klinger, J., Koepke, K. M., Lee, C. C., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00005 · Cited by 23
Shapiro, B. S., Daneshmand, S. T., Garner, F. C., Aguirre, M., Hudson, C., & Thomas, S. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.050 · Cited by 664
Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study
Ortner, M. E. J., Caca, K., Berr, F., Liebetruth, J., Mansmann, U., Huster, D., Voderholzer, W., Schachschal, G., Mössner, J., & Lochs, H. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.07.015 · Cited by 608
Allegra, C. J., Yothers, G., O'Connell, M. J., Sharif, S., Petrelli, N. J., Colangelo, L. H., Atkins, J. N., Seay, T. E., Fehrenbacher, L., Goldberg, R. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.0855 · Cited by 593
Sequential hypothesis testing with Bayes factors: Efficiently testing mean differences.
Schönbrodt, F. D., Wagenmakers, E.-J., Zehetleitner, M., & Perugini, M. (2017) · Psychological Methods · doi:10.1037/met0000061 · Cited by 567
Gulick, R. M., Ribaudo, H. J., Shikuma, C. M., Lustgarten, S., Squires, K. E., Meyer, W. A., Acosta, E. P., Schackman, B. R., Pilcher, C. D., Murphy, R. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031772 · Cited by 522
Meyskens, F. L., McLaren, C. E., Pelot, D., Fujikawa-Brooks, S., Carpenter, P. M., Hawk, E., Kelloff, G., Lawson, M. J., Kidao, J., McCracken, J., et al. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0042 · Cited by 517
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine
Weisbord, S. D., Gallagher, M., Jneid, H., Garcia, S., Cass, A., Thwin, S.-S., Conner, T. A., Chertow, G. M., Bhatt, D. L., Shunk, K., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710933 · Cited by 512
Adaptive design methods in clinical trials–a review
Chow, S.-C., & Chang, M. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-11 · Cited by 482
“Various stopping boundaries based on different boundary functions for controlling an overall type I error rate are available in the literature (see, e.g., Lan and DeMets, 1987; Wang and Tsiatis, 1987; Rosenberger et al., 2001; Jennison and Turnbull, 2000, 2005; Chow and Chang, 2006).”
Inhaled Nitric Oxide in Preterm Infants Undergoing Mechanical Ventilation
Ballard, R. A., Truog, W. E., Cnaan, A., Martin, R. J., Ballard, P. L., Merrill, J. D., Walsh, M. C., Durand, D. J., Mayock, D. E., Eichenwald, E. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061088 · Cited by 484
Olanzapine for the prevention of chemotherapy-induced nausea and vomiting.
Navari, R. M., Qin, R., Ruddy, K. J., Liu, H., Powell, S. F., Bajaj, M., Dietrich, L., Biggs, D., Lafky, J. M., & Loprinzi, C. L. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515725 · Cited by 452
Biau, D. J., Kernéis, S., & Porcher, R. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0346-9 · Cited by 428
Uterine-Artery Embolization versus Surgery for Symptomatic Uterine Fibroids
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062003 · Cited by 408
Fowler, V. G., Allen, K. B., Moreira, E. D., Moustafa, M., Isgro, F., Boucher, H. W., Corey, G. R., Carmeli, Y., Betts, R., Hartzel, J. S., et al. (2013) · JAMA · doi:10.1001/jama.2013.3010 · Cited by 372
Patel, J. D., Socinski, M. A., Garon, E. B., Reynolds, C. H., Spigel, D. R., Olsen, M. R., Hermann, R. C., Jotte, R. M., Beck, T., Richards, D. A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.9626 · Cited by 370
Randomized Clinical Trials With Biomarkers: Design Issues
Freidlin, B., McShane, L. M., & Korn, E. L. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp477 · Cited by 369
Adaptive increase in sample size when interim results are promising: a practical guide with examples
Mehta, C. R., & Pocock, S. J. (2011) · Statistics in Medicine · doi:10.1002/sim.4102 · Cited by 367
Fan, V. S., Gaziano, J. M., Lew, R., Bourbeau, J., Adams, S. G., Leatherman, S., Thwin, S. S., Huang, G. D., Robbins, R., Sriram, P. S., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-10-201205150-00003 · Cited by 338
Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial
(2013) · Contemporary Clinical Trials · doi:10.1016/j.cct.2013.09.014 · Cited by 310
Successful aging: Advancing the science of physical independence in older adults
Anton, S. D., Woods, A. J., Ashizawa, T., Barb, D., Buford, T. W., Carter, C. S., Clark, D. J., Cohen, R. A., Corbett, D. B., Cruz-Almeida, Y., et al. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.09.005 · Cited by 292
Chakraborty, B., & Murphy, S. A. (2014) · Annual Review of Statistics and Its Application · doi:10.1146/annurev-statistics-022513-115553 · Cited by 286
Mills (2010) · Clinical Epidemiology · doi:10.2147/clep.s9242 · Cited by 281
Optimal Adaptive Designs for Binary Response Trials
Rosenberger, W. F., Stallard, N., Ivanova, A., Harper, C. N., & Ricks, M. L. (2001) · Biometrics · doi:10.1111/j.0006-341x.2001.00909.x · Cited by 270
Issues in data monitoring and interim analysis of trials
Grant, A., Altman, D., Babiker, A., Campbell, M., Clemens, F., Darbyshire, J., Elbourne, D., McLeer, S., Parmar, M., Pocock, S., et al. (2005) · Health Technology Assessment · doi:10.3310/hta9070 · Cited by 269
Adaptive clinical trials in oncology
Berry, D. A. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.165 · Cited by 267
Generalized pairwise comparisons of prioritized outcomes in the two‐sample problem
Buyse, M. (2010) · Statistics in Medicine · doi:10.1002/sim.3923 · Cited by 258
Sequential methods for random‐effects meta‐analysis
Higgins, J. P. T., Whitehead, A., & Simmonds, M. (2011) · Statistics in Medicine · doi:10.1002/sim.4088 · Cited by 258
Ryan, D. H., Lingvay, I., Colhoun, H. M., Deanfield, J., Emerson, S. S., Kahn, S. E., Kushner, R. F., Marso, S., Plutzky, J., Brown-Frandsen, K., et al. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.07.008 · Cited by 249
Aggarwal, S. P., Zinman, L., Simpson, E., McKinley, J., Jackson, K. E., Pinto, H., Kaufman, P., Conwit, R. A., Schoenfeld, D., Shefner, J., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70068-5 · Cited by 195
Time-uniform, nonparametric, nonasymptotic confidence sequences
Howard, S. R., Ramdas, A., McAuliffe, J., & Sekhon, J. (2021) · The Annals of Statistics · doi:10.1214/20-aos1991 · Cited by 190
Dose finding—a challenge in statistics.
Bretz, F., Hsu, J., Pinheiro, J., & Liu, Y. (2008) · Biometrical Journal · doi:10.1002/bimj.200810438 · Cited by 101
Berwaerts, J., Melkote, R., Nuamah, I., & Lim, P. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.01.047 · Cited by 101
Lonial, S., Popat, R., Hulin, C., Jagannath, S., Oriol, A., Richardson, P. G., Facon, T., Weisel, K., Larsen, J. T., Minnema, M. C., et al. (2022) · The Lancet Haematology · doi:10.1016/s2352-3026(22)00290-3 · Cited by 101
Hierarchical testing of multiple endpoints in group‐sequential trials
Glimm, E., Maurer, W., & Bretz, F. (2010) · Statistics in Medicine · doi:10.1002/sim.3748 · Cited by 89
Guidance on interim analysis methods in clinical trials
Ciolino, J. D., Kaizer, A. M., & Bonner, L. B. (2023) · Journal of Clinical and Translational Science · doi:10.1017/cts.2023.552 · Cited by 66
A general inefficacy interim monitoring rule for randomized clinical trials
Freidlin, B., Korn, E. L., & Gray, R. (2010) · Clinical Trials · doi:10.1177/1740774510369019 · Cited by 64
Dimairo, M., Pallmann, P., Wason, J., Todd, S., Jaki, T., Julious, S. A., Mander, A. P., Weir, C. J., Koenig, F., Walton, M. K., et al. (2020) · Trials · doi:10.1186/s13063-020-04334-x · Cited by 58
Interpretation of clinical trials that stopped early
Viele, K., McGlothlin, A., & Broglio, K. (2016) · JAMA · doi:10.1001/jama.2016.2628 · Cited by 48
(2010) · PubMed · Cited by 19
Statistical rules for safety monitoring in clinical trials
Martens, M. J., & Logan, B. R. (2024) · Clinical Trials · doi:10.1177/17407745231203391 · Cited by 10
Stop Guessing When to Stop Testing: Efficient Model Evaluation with Just Enough Data
Arviv, O., Greenewald, K., Perlitz, Y., Mulian, H., Shmueli-Scheuer, M., & Choshen, L. (2026) · Findings of the Association for Computational Linguistics: ACL 2026 · doi:10.18653/v1/2026.findings-acl.43
Metadata
- Authors
- Jennison, C., & Turnbull, B. W.
- Venue
- Chapman & Hall/CRC eBooks
- Publisher
- Chapman and Hall/CRC
- Published
- 1999-09-15
- OpenAlex
- W1571725767
- Cited by
- 1,336
- References
- 0
- FWCI
- 4.33
- Type
- book
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.